Status:
COMPLETED
CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
COPD Exacerbation Acute
Eligibility:
All Genders
18+ years
Brief Summary
Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) are one of the chief causes for admission to Emergency Department. AECOPD is a significant cause for mortality and morbidity world...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is an important health concern worldwide and causes serious mortality and morbidities. Although prevalences can differ across different countries, it was p...
Eligibility Criteria
Inclusion
- being older than 18 years old
- having been diagnosed with COPD by a specialist
- fulfilling the definition of an exacerbation set by GOLD 2024 guide which are having increased dyspnea, cough and sputum in a timespan of less than 14 days with or without tachypnea and tachycardia
- having signed the consent and approval form.
Exclusion
- being younger than 18 years old
- not having been diagnosed with COPD by a specialist, not fulfilling the definition of an exacerbation set by GOLD 2024 guide
- refusing to sign the consent and approval form.
Key Trial Info
Start Date :
February 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT06514599
Start Date
February 15 2023
End Date
April 15 2024
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health, University of Health Sciences, İstanbul Kanuni SUltan Suleyman TRaining and Research Hospital
Istanbul, Küçükçekmece, Turkey (Türkiye), 34303